Table 4 Serum levels of ProBNP (pg/ml) -bezafibrate vs placebo-
| Â | Bezafibrate (n = 58) | Placebo (n = 50) |
|---|---|---|
Baseline | Â | Â |
   Geometric mean (95% CI) | 154 (118–202) | 219 (168–284) |
   Median (Interquartile range) | 151 (89–335) | 215 (101–468) |
   Mean ± SD | 254 ± 295 | 331 ± 326 |
P = 0.07 (t-test for ln-transformed values) | ||
P = 0.11 (Kruskal-Wallis test) | ||
2-year follow-up | Â | Â |
   Geometric mean (95% CI) | 206 (157–271) | 209 (150–292) |
   Median (Interquartile range) | 230 (100–348) | 224 (82–503) |
   Mean ± SD | 374 ± 552 | 389 ± 442 |
P = 0.95 (t-test for ln-transformed values) | ||
P = 0.85 (Kruskal-Wallis test) | ||